MUMBAI: Ceuticoz is gearing up for a growth spurt. The medical-grade skincare brand has promoted Arvin Mondal to head of marketing, tasking him with building a global footprint as the company chases revenues of Rs 150-200 crore by financial year 2029-30—a compound annual growth rate of 30-35 per cent.
Mondal, who previously steered the brand’s international expansion, will oversee marketing across retail and e-commerce whilst leading regional campaigns in Britain, the European Union, the Gulf Cooperation Council states and south-east Asia. His brief: turn a dermatologist-trusted label into a household name.
Ceuticoz projects revenues of Rs 50 crore in FY 2025-26, up from a record monthly turnover of Rs 4 crore in November-December 2024. The brand already operates in over 10 countries, including Canada, Kenya and South Africa. America, the United Arab Emirates and Saudi Arabia are next on the list, with a target of 25-plus markets by 2030.
“Arvin has played a vital role in the company’s international expansion,” says managing director Sukhbir Singh Chimni. “His new role allows him to craft our brand’s story as we move towards becoming a globally acclaimed skincare brand, driven by science and authenticity.”
Founded in 2005, Ceuticoz positions itself as evidence-based and clinically proven—skincare that doctors recommend rather than influencers hawk.
Whether that pitch resonates beyond dermatology clinics will determine if Mondal’s targets are ambitious or merely optimistic. Either way, he’s got skin in the game.
